Bin Guo

5.9k total citations · 4 hit papers
95 papers, 4.7k citations indexed

About

Bin Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bin Guo has authored 95 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 23 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Bin Guo's work include MicroRNA in disease regulation (12 papers), RNA Interference and Gene Delivery (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). Bin Guo is often cited by papers focused on MicroRNA in disease regulation (12 papers), RNA Interference and Gene Delivery (9 papers) and Histone Deacetylase Inhibitors Research (9 papers). Bin Guo collaborates with scholars based in China, United States and Pakistan. Bin Guo's co-authors include Sundus Jabeen Amina, John C. Reed, Dayong Zhai, Arnold C. Satterthwait, Liye Wang, Kwang Bog Cho, Zuoxu Xie, Gabriel Tao, Yan Li and Sathish K.R. Padi and has published in prestigious journals such as Nature, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Bin Guo

92 papers receiving 4.6k citations

Hit Papers

Humanin peptide suppresses apoptosis by interfering with ... 2003 2026 2010 2018 2003 2019 2017 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Guo China 32 3.0k 1.4k 496 493 395 95 4.7k
Galia Blum Israel 33 1.9k 0.6× 973 0.7× 635 1.3× 923 1.9× 355 0.9× 59 3.7k
John Hood United States 30 4.2k 1.4× 938 0.7× 410 0.8× 1.1k 2.3× 648 1.6× 56 7.2k
Hua Guo China 38 2.4k 0.8× 1.2k 0.8× 513 1.0× 816 1.7× 366 0.9× 161 4.5k
Wei Yan China 39 3.2k 1.0× 974 0.7× 297 0.6× 736 1.5× 705 1.8× 118 4.6k
Prakash Gangadaran South Korea 34 2.4k 0.8× 1.1k 0.8× 674 1.4× 509 1.0× 644 1.6× 129 4.1k
Paolo E. Porporato Italy 40 4.2k 1.4× 2.8k 1.9× 495 1.0× 1.0k 2.0× 713 1.8× 85 7.2k
Lili Wang China 36 2.7k 0.9× 2.0k 1.4× 276 0.6× 418 0.8× 237 0.6× 172 4.3k
Tao Yi China 36 1.9k 0.6× 831 0.6× 181 0.4× 673 1.4× 868 2.2× 206 4.1k
Gopal C. Kundu India 50 3.6k 1.2× 1.5k 1.0× 623 1.3× 1.5k 3.1× 877 2.2× 134 7.3k

Countries citing papers authored by Bin Guo

Since Specialization
Citations

This map shows the geographic impact of Bin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Guo more than expected).

Fields of papers citing papers by Bin Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Guo. The network helps show where Bin Guo may publish in the future.

Co-authorship network of co-authors of Bin Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Guo. A scholar is included among the top collaborators of Bin Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Guo. Bin Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jia, Yuting, Bin Guo, Wenbin Zhang, et al.. (2023). Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy. Frontiers in Oncology. 13. 1110207–1110207. 12 indexed citations
3.
Cao, Yuntai, Jing Zhang, Lele Huang, et al.. (2023). Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics. Japanese Journal of Radiology. 41(11). 1236–1246. 8 indexed citations
4.
Liu, Jingwen, et al.. (2020). A CRISPR-Cas9 repressor for epigenetic silencing of KRAS. Pharmacological Research. 164. 105304–105304. 21 indexed citations
5.
Wang, Qiang, et al.. (2020). Performance of urea-mediated dissociation in reducing false-positive of 2019-nCoV IgM test. Zhonghua jianyan yixue zazhi. 43(12). 2 indexed citations
6.
Xiu, Lei, Xiaohong Hu, Zhang Tin, et al.. (2020). HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression. Cellular Signalling. 72. 109631–109631. 30 indexed citations
7.
Xu, Xinjian, Yang� Yang, Limin Cao, et al.. (2019). Lymph Node Metastasis and Recurrence in Primary Small Cell Carcinoma of the Esophagus: A Retrospective Study of 125 Cases. Cancer Biotherapy and Radiopharmaceuticals. 34(7). 459–463. 5 indexed citations
8.
Li, Leilei, et al.. (2018). Mechanisms of resistance to chemotherapy and radiotherapy in hepatocellular carcinoma. Translational Cancer Research. 7(3). 765–781. 10 indexed citations
9.
Sun, Bin, Bin Guo, Bo Wu, et al.. (2017). Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016. Osteoporosis International. 29(3). 635–642. 25 indexed citations
10.
Wu, Jinghua, Jun Shi, Hui Wang, et al.. (2017). CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma. World Journal of Gastroenterology. 23(13). 2308–2308. 27 indexed citations
11.
Zhao, Lingyu, Dongdong Tong, Meng Xue, et al.. (2017). MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2–ERK1/2 signaling pathway by upregulating GIT1. Oncogenesis. 6(7). e368–e368. 58 indexed citations
12.
Han, Linlin, et al.. (2017). MicroRNA let-7f-5p regulates neuronal differentiation of rat bone marrow mesenchymal stem cells by targeting Par6α. Biochemical and Biophysical Research Communications. 495(1). 1476–1481. 11 indexed citations
13.
Sun, Meiyan, et al.. (2016). Vitamin D Enhances the Efficacy of Irinotecan through miR-627–Mediated Inhibition of Intratumoral Drug Metabolism. Molecular Cancer Therapeutics. 15(9). 2086–2095. 31 indexed citations
14.
Xu, Yi, Xiaoyu Yang, Pinjing Zhao, et al.. (2016). Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2. Free Radical Biology and Medicine. 96. 67–77. 27 indexed citations
15.
Zhang, Qi, Sathish K.R. Padi, D. J. Tindall, & Bin Guo. (2014). Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31. Cell Death and Disease. 5(10). e1486–e1486. 75 indexed citations
16.
Sun, Jie, et al.. (2011). Flavonoids of Rhizoma Sparaganii Induce S/G_2 Stage Arrest in A549 and MCF-7 Cells. Tianran chanwu yanjiu yu kaifa. 23(2). 224. 9 indexed citations
17.
Li, Yongming, Xia Li, & Bin Guo. (2010). Chemopreventive Agent 3,3′-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases. Cancer Research. 70(2). 646–654. 89 indexed citations
18.
Guo, Bin, Dayong Zhai, Edelmira Cabezas, et al.. (2003). Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature. 423(6938). 456–461. 513 indexed citations breakdown →
20.
Guo, Bin, Wieland Voigt, U. Vanhoefer, et al.. (1998). Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1401(3). 265–276. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026